Dr. Arif Hussain, MD
Claim this profileUniversity of Maryland
Studies Prostate Cancer
Studies Renal Cell Carcinoma
8 reported clinical trials
17 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
White blood cell count (WBC)
ALT
2Renal Cell Carcinoma
PD-L1
AST
ALT
Affiliated Hospitals
Clinical Trials Arif Hussain, MD is currently running
Radium-223 + Docetaxel
for Prostate Cancer
The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone. Earlier studies helped show that the combination is safe, but the combination has not been proven to work better than either drug alone. The goal of this study is to find out if combining docetaxel and radium-223 is better than giving either drug by itself.
Recruiting2 awards Phase 323 criteria
Lutetium (177Lu) Vipivotide Tetraxetan
for Prostate Cancer
The purpose of this study is to evaluate the efficacy and safety of lutetium (177Lu) vipivotide tetraxetan (AAA617) in participants with oligometastatic prostate cancer (OMPC) progressing after definitive therapy to their primary tumor. The data generated from this study will provide evidence for the treatment of AAA617 in early-stage prostate cancer patients to control recurrent tumor from progressing to fatal metastatic disease while preserving quality of life by delaying treatment with androgen deprivation therapy (ADT).
Recruiting2 awards Phase 36 criteria
More about Arif Hussain, MD
Clinical Trial Related7 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Arif Hussain, MD has experience with
- Docetaxel
- [177Lu]Ludotadipep
- Lutetium Lu 177 Vipivotide Tetraxetan
- ONC-392
- Nivolumab
- Radium Ra 223 Dichloride
Breakdown of trials Arif Hussain, MD has run
Prostate Cancer
Renal Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Arif Hussain, MD specialize in?
Arif Hussain, MD focuses on Prostate Cancer and Renal Cell Carcinoma. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are White blood cell count (WBC).
Is Arif Hussain, MD currently recruiting for clinical trials?
Yes, Arif Hussain, MD is currently recruiting for 4 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Arif Hussain, MD has studied deeply?
Yes, Arif Hussain, MD has studied treatments such as Docetaxel, [177Lu]Ludotadipep, lutetium Lu 177 vipivotide tetraxetan.
What is the best way to schedule an appointment with Arif Hussain, MD?
Apply for one of the trials that Arif Hussain, MD is conducting.
What is the office address of Arif Hussain, MD?
The office of Arif Hussain, MD is located at: University of Maryland, Baltimore, Maryland 21201 United States. This is the address for their practice at the University of Maryland.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.